AURX · ISSUER CIK 1091596
Nuo Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Nuo Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 202621:46 | Aug 28, 2026from Aug 27, 2026 | AURX | CEO/CFO, Director | A · Grant | $1.09 | +8,773 | 2,070,000 | +0% | $10K |